A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate
2016 · CNS Drugs · 12 citations
https://doi.org/10.1007/s40263-016-0354-3